Facebook
Twitter
LinkedIn
Forward2nd Annual Duke Heart General Cardiology Update
In order to reduce the incidence of cardiovascular disease and its negative implications for the health of patients and our health care system, physicians must be aware of and understand new evidence as rapidly as possible and we must facilitate the adoption of practice guidelines by physicians and other health care providers responsible for the cardiovascular care of patients. Primary care physicians are on the front lines of patient care and must keep abreast of new developments and understand the recommendations to apply them effectively in their medical practice. Thus, there is an educational need to present cutting-edge research clearly and concisely so that providers may make informed changes to their medical practice with confidence. This program will highlight various therapeutic agents, technologies, diagnostic procedures, and means of evaluating patients for appropriate treatment in order to improve patient outcomes. The overall goal of this program is to present a balanced perspective to common clinical problems in a clear and concise manner so that providers may make informed changes to their medical practice with confidence.
Target Audience
Physicians (cardiology, primary care)
Learning Objectives
At the conclusion of this activity, participants should be able to:
- Identify current lipid guidelines for evaluation and treatment of patients with dyslipidemia, and recognize optimal blood pressure readings in patients with cardiovascular disease
- Describe the best practices for when to refer patients with cardiovascular disease for cardiac rehabilitation
- Learn about the use of NOACs in patients with valvular heart disease and those with end stage renal disease
- Understand the role of the WCD in patients with an acute MI
- Select appropriate atrial fibrillation patients for ablation
- Describe how to manage patients with bradyarrhythmias according to the most up to date professional guidelines
- Restate what professional guidelines recommend regarding use of novel heart failure medications
- Describe current data on which patients are most likely to benefit from revascularization or medical therapy as a treatment strategy for PAD
- Discuss how new developments in imaging technologies to guide disease diagnosis and management
- Summarize current data and ongoing research for using dual antiplatelet therapy after drug-eluting stents in patients with acute coronary syndromes
- Recognize benefits and challenges of treatment options for aortic stenosis patients who require valve replacement
Available Credit
- 6.50 AMA PRA Category 1 Credit(s)™
- 6.50 Attendance